Kuwahira Ichiro, Iwamoto Tokuzen
Department of Medicine, Tokai University Tokyo Hospital.
Nihon Rinsho. 2003 Dec;61(12):2138-43.
The prevalence and natural history of cor pulmonale in COPD are not yet clear. Factors that are known to contribute to the development of pulmonary hypertension in COPD include hypoxic pulmonary vasoconstriction(HPV), remodeling of pulmonary arteries, destruction of the pulmonary capillary bed and polycythemia. In addition, impaired mechanisms of endothelium-dependent vasodilation such as reduced NO synthesis or release, and abnormal secretion of vasoconstrictor peptides play an important role in the development of pulmonary hypertension. These factors can lead to right ventricular hypertrophy and right heart failure. Pulmonary hypertension develops late in the course of COPD (stage III) usually after the development of severe hypoxemia and is associated with a poor prognosis of the disease.
慢性阻塞性肺疾病(COPD)中肺心病的患病率及自然病史尚不清楚。已知导致COPD患者发生肺动脉高压的因素包括低氧性肺血管收缩(HPV)、肺动脉重塑、肺毛细血管床破坏及红细胞增多症。此外,内皮依赖性血管舒张机制受损,如一氧化氮(NO)合成或释放减少,以及血管收缩肽分泌异常,在肺动脉高压的发生中起重要作用。这些因素可导致右心室肥厚和右心衰竭。肺动脉高压通常在COPD病程晚期(Ⅲ期),严重低氧血症出现后发生,且与疾病的不良预后相关。